Fundamental Analysis
54 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +155.2% | -263.0% | 2 / 3 | +982.2% | -60.92 pp | +1873.07 pp | -77.4% | 1.41 | — | 1,9 | +982,2% | 1,7 | +155,2% | — | -4.98 | — |
| Pts | 12 | 0 | 8 | 12 | 0 | 12 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 4.900 (close price on 2026-09-14)EPS (TTM): −483,1
Financial charts
1.Revenue & growth
VND bn1,86Q3/26
1.Revenue & growth
VND bn1,86Q3/26
2.Profit & growth
VND bn1,69Q3/26
3.Profit mix (Penman)
VND bn-5,40Q3/26
4.Margins & cost structure
%26.6%Q3/26
5.Returns & cash cycle
% · days-11.1%Q3/26
6.Earnings quality & cash
VND bn47,8Q3/26
7.Asset structure
VND bn110Q3/26
8.Funding & debt health
VND bn · times110Q3/26
9.Revenue backlog
VND bn63,4Q3/26
10.Valuation
times · %-13,3×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %115Q3/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26